Reproducibility and Clinical Value of the Trough-to-Peak Ratio of the Antihypertensive Effect
- 1 September 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 32 (3) , 424-429
- https://doi.org/10.1161/01.hyp.32.3.424
Abstract
Abstract —The objectives of our study were to assess the reproducibility of the trough-to-peak ratio (T/P) and to see whether a high T/P is accompanied by more organ protection or vice versa. The study included 175 (mean±SD age, 51±9 years) subjects with mild-moderate essential hypertension who had echocardiographic evidence of left ventricular (LV) hypertrophy taken from the SAMPLE study (Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation), an open-label multicenter study. The study included a 3-week washout pretreatment period, a 12-month treatment period with lisinopril (n=84) or lisinopril plus hydrochlorothiazide (n=91) once daily, and a 4-week placebo follow-up period. Results of 24-hour ambulatory blood pressure monitoring and echocardiographic determination of left ventricular mass index (LVMI) were obtained before and after 3 and 12 months of treatment. T/Ps were computed in each patient by dividing the systolic and diastolic blood pressure changes at trough (changes in the last 2 hours of the monitoring period) by those at peak (average of the 2 adjacent hours with the maximal blood pressure reduction between the 2nd and 8th hour from drug intake) after 3 and 12 months of treatment. Average 24-hour blood pressure was similarly reduced at 3 and 12 months. Trough blood pressure changes at 3 and 12 months were closely correlated, as were the corresponding peak blood pressure changes. However, the 3- and 12-month T/Ps correlated to a lesser degree ( r <0.42). Furthermore, the reduction of LVMI induced by treatment was similarly correlated with the treatment-induced reduction in 24-hour average, trough, and peak blood pressures but not with the T/Ps. This was also evident when the contribution to LV hypertrophy regression by 24-hour blood pressure changes and T/Ps was assessed in a multivariate regression analysis. In patients with a T/P ≥0.5 or <0.5, the regression of LVMI was similar. In conclusion, peak and trough blood pressure changes are reproducible and predict the regression of LVMI induced by treatment as well as average 24-hour blood pressure. T/Ps are less reproducible, and their value does not predict regression of organ damage by antihypertensive treatment.Keywords
This publication has 18 references indexed in Scilit:
- The Trough-to-Peak Ratio as an Instrument to Evaluate Antihypertensive DrugsHypertension, 1995
- Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspectsJournal Of Hypertension, 1995
- Trough-To-Peak Versus Surface Ratio in the Assessment of Antihypertensive AgentsBlood Pressure, 1995
- FDA Guidelines on TroughJournal of Cardiovascular Pharmacology, 1994
- TroughJournal Of Hypertension, 1994
- Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure.Hypertension, 1992
- Clinical Significance of Left Ventricular HypertrophyJournal of Cardiovascular Pharmacology, 1991
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Standardization of M-mode echocardiographic left ventricular anatomic measurementsJournal of the American College of Cardiology, 1984